Paritosh Garg: From Replacing Platelets to Stimulating Platelet Production
Paritosh Garg, Associate Consultant at Fortis Memorial Research Institute, India, shared a post on LinkedIn about a recent article by Raoel Maan et al., published in Drugs, adding:
“Thrombocytopenia in chronic liver disease is not just a platelet-count problem.
It influences procedural planning, antiviral therapy, transfusion decisions, and thrombotic risk assessment.
This review highlights an important shift in supportive care:
From replacing platelets to stimulating platelet production.
Thrombopoietin receptor agonists opened a new therapeutic space, but the key message remains clinical judgment.
In CLD, the question is not only:
‘Can we increase the platelet count?’
It is also:
‘At what thrombotic cost, and in which patient?’
A practical reminder that supportive care in hematology is never ‘supportive only’ — it often determines whether definitive care can safely proceed.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge